APYX vs REGN · rev $48.1M vs P/E 14, rev $14.34B
Apyx Medical Inc (APYX) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
APYX currently screens at market cap $179.6M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the APYX and REGN stock pages for the full models.
Not investment advice.